Clinical Trial Update: The Effects of PXR Activation on Hepatic Fat Content [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effects of pregnane X receptor (PXR) activation on hepatic fat content in non-alcoholic fatty liver disease; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: University of Oulu | Conditions: Non-alcoholic Fatty Liver Disease | Phase 4 | Status: COMPLETED